Correlation Between Spyre Therapeutics and 264399DK9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 264399DK9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 264399DK9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and DUKE PWR LLC, you can compare the effects of market volatilities on Spyre Therapeutics and 264399DK9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 264399DK9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 264399DK9.

Diversification Opportunities for Spyre Therapeutics and 264399DK9

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Spyre and 264399DK9 is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DUKE PWR LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DUKE PWR LLC and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 264399DK9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DUKE PWR LLC has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 264399DK9 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 264399DK9

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 264399DK9. In addition to that, Spyre Therapeutics is 5.01 times more volatile than DUKE PWR LLC. It trades about -0.27 of its total potential returns per unit of risk. DUKE PWR LLC is currently generating about 0.02 per unit of volatility. If you would invest  10,495  in DUKE PWR LLC on September 4, 2024 and sell it today you would earn a total of  28.00  from holding DUKE PWR LLC or generate 0.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.48%
ValuesDaily Returns

Spyre Therapeutics  vs.  DUKE PWR LLC

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
DUKE PWR LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DUKE PWR LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 264399DK9 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics and 264399DK9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and 264399DK9

The main advantage of trading using opposite Spyre Therapeutics and 264399DK9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 264399DK9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 264399DK9 will offset losses from the drop in 264399DK9's long position.
The idea behind Spyre Therapeutics and DUKE PWR LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world